Best Response

Not sure about biotech in particular, but street sentiment is that JPM has the best HC group. That being said, every deal, sector agnostic, is strongly contested by JPM, GS, MS, and BAML, and the groups at GS, MS, and BAML are pretty strong in HC as well and have landed some big deals over the last few years in life sciences and biotech. If you read up about recent pharma megablockbusters (Actavis-Allergan, Johnson & Johnson Acletion, Shire Baxalta, etc.) you will find that at least two of those four banks are on every single deal in the last decade. All of those groups kill it, so find the right firm within that elite BB class and the HC group won't disappoint.

 

Hi WWilson, no, I never sleep and so I can respond to any lonely threads (like this one) at all hours of the night. Impressive, I know ;-)

  • Anyone here have a corporate/business development background? Have a couple questions for anyone that has worked in corporate development.. let me know. ...
  • Working within Corporate/Business Development I know that Corp/Bus Dev is basically in house m&a. What are the reasons for going into this area of work compared to PE or staying in banking (ie better work life balance)? From what I've heard the pay in c/b dev is not as nice as banking or PE, ...
  • Corporate Development Manager- Q&A Corporate/Business Development @ a top 5 Public Pharma Company. ~9 months in role. Base Salary $150k. Bonus = 20% of ... known Corporate Development field as well as exit ops out of Big 4 Audit. So I wanted to share my story ... Applying to top 5 schools. Post MBA, either direct to PE, back to Corp Development at Director level, or ...
  • Sales and Trading to Corporate/Business Development this program. I would like to work for a corporate within strategy. I'm not that set on it being ...
  • Corporate/Business Strategy in F500- Found my interest I discover I am interested in marketing, meanwhile dealing with business clients, enjoy international ... exposure and going on business trips etc. In the future, I would like to become one of the analyst in ... corporate strategy of F500 companies. For example, I will enjoy making decisions in areas of bringing ...
  • Stimulants 101: How to wake yourself up and get shit done (without destroying your long-term health) mess up your health for years if you're not careful. So before you go out and start popping pills ... The corporate PEDs (performance enhancing drugs) There's a simple reason for why people take so ... my business, I do 1-on-1 coaching with a select few clients. These are ambitious individuals that ...
  • Corporate Development Hierarchy I'm interested in transitioning into Corporate/Business Development and am looking to reach ... senior or junior (i.e. VP in Investment Bank), and I was wondering if anyone had a good idea of the ...
  • More suggestions...

No promises, but maybe one of our professional members will share their wisdom: shobhitgupta123 SouthLoopMonkey jss09

Hope that helps.

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

CS was only a buy-side advisor to HCA along with MS.

JP, BofA, Citi and ML were the sell-side advisors. Bof A is on the left, Citi and ML are on the right and JP is somewhere in between, although technically on the right.

---------------- Account Inactive
 
buysideanalyst:
JP, BofA, Citi and ML were the sell-side advisors. Bof A is on the left, Citi and ML are on the right and JP is somewhere in between, although technically on the right.

Could you explain what the "left, right" stuff means?

 
buysideanalyst:
CS was only a buy-side advisor to HCA along with MS.

JP, BofA, Citi and ML were the sell-side advisors. Bof A is on the left, Citi and ML are on the right and JP is somewhere in between, although technically on the right.

Ooops. Switched buyside and sellside above. Duh.

I wonder who initiated this transaction? HCA or the sponsors? Anyone know? I was assuming the sponsors made the initial move, but maybe HCA was 'exploring strategic alternatives' beforehand.

---------------- Account Inactive
 

Harum quaerat veritatis quod autem soluta minus. Consequatur quo commodi tenetur. Explicabo ad suscipit fuga voluptatibus praesentium.

Vero commodi repellendus quasi quia qui. Aut eligendi tempora fugiat alias quas. Dolores repellendus numquam harum ut voluptatem sed. Sapiente asperiores et aut molestias possimus ipsa inventore.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
kanon's picture
kanon
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”